News | Nuclear Imaging | September 27, 2018

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

New high-sensitivity PET tracers, trends toward solid state and dual-head gamma cameras expected to push total market revenue past $75 million by 2029

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

September 27, 2018 — Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of gamma cameras. Further, the numerous developments in radionucleotides are anticipated to favor the adoption of solid state cameras and mobile gamma cameras. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

Single photon emission computed tomography (SPECT) is currently the biggest application of gamma cameras given the low cost, large suite of radioisotopes and expanded use cases. According to FMI, however, positron emission tomography (PET) is anticipated to witness the fastest growth in terms of adoption, owing to the greater special resolution and sensitivity brought about by the use of positron emitting radioisotopes that provide more energy, contrast and special resolution.

According to FMI analysis, the high costs of PET as compared to SPECT are expected to be negated in the wake of development of high sensitivity and selective tracers. FMI predicts a growth rate of 4.8 percent for the mobile gamma cameras market during the 10-year period from 2018 to 2028. Revenue from the sales of mobile gamma cameras is estimated to reach $75.2 million by the end of 2028, up from $47.2 million in 2018.

Being a high-value, low-volume market, technology plays a vital role in the mobile gamma cameras market, where the technologically advanced products are priced at a premium. The development of solid state sensors is slowly replacing the photomultiplier tube and this represents the biggest technological development in the market followed by miniaturization.

A notable trend being observed in the market is the shift towards dual-head gamma cameras. Single-head mobile gamma cameras have certain inherent disadvantages such as slow speed and lower density count, leading to the inability to perform different types of tests. This has resulted in an elevated demand for multiple-head cameras. Dual-head cameras increase total counts per stop, resulting in relatively lesser scan time and better image quality, leading to enhanced accuracy in diagnosis.

Further, according to FMI, the latest mobile gamma cameras come with newer and better functionalities. Owing to advances in electronic components and software, modern mobile gamma cameras include advanced reconstruction algorithms and periodic updates that help boost scan speeds and image correction parameters. Advanced gamma camera software also facilitates more personalized patient scans by tracking patient activity and performing appropriate scans.

The full market intelligence outlook from FMI can be downloaded here.

For more information: www.futuremarketinsights.com

Related Content

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Feinstein Institutes' Thomas Chaly, Ph.D., poses in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical R...
Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments
 Prostate cancer MRI
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative radiopharm
Image by Dr. Manuel González Reyes from Pixabay

Image by Dr. Manuel González Reyes from Pixabay 

News | SPECT Imaging | November 08, 2019
November 8, 2019 — Using ground-breaking technology, researchers at the...
Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can bee seen in this photo on either side of the patient bed. These can be rotated above the patient.

Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can be seen in this photo on either side of the patient bed. These can be rotated above the patient.

Feature | Nuclear Imaging | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660
 Phoenix’s fusion neutron generation technology.
News | Radiopharmaceuticals and Tracers | October 28, 2019
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term